2025-12-20 - Analysis Report
Okay, here's a comprehensive analysis of Albemarle Corp (ALB) based on the data provided, presented in a clear and organized manner.

**1. Return Rate Comparison**

*   **Ticker:** ALB (Albemarle Corp)
*   **Company Overview:** Albemarle Corp is a global specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.
*   **ALB Cumulative Return:** 40.97%
*   **S&P 500 (VOO) Cumulative Return:** 100.88%
*   **Divergence:** -73.1 (ALB is underperforming the S&P 500)
*   **Relative Divergence:** 15.2 (Indicates ALB's current divergence is near its historical low.)

**Analysis:** Albemarle has significantly underperformed the S&P 500 over the period examined. The relative divergence suggests this underperformance is near its worst point historically. This indicates potential opportunity if ALB is expected to revert to the mean or outperform in the future.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha    | Beta   | Cap(B) |
|------------|---------|-------|----------|--------|--------|
| 2015-2017  | 85.0%   | 68.0% | 56.0%    | 0.1    | 15.1   |
| 2016-2018  | 9.0%    | 68.0% | -6.0%    | 0.0    | 9.1    |
| 2017-2019  | -44.0%  | 73.9% | -66.0%   | 0.1    | 8.6    |
| 2018-2020  | 44.0%   | 79.4% | 20.0%    | 0.2    | 17.4   |
| 2019-2021  | 149.0%  | 79.4% | 103.0%   | -0.1   | 27.5   |
| 2020-2022  | 148.0%  | 79.9% | 149.0%   | 0.5    | 25.5   |
| 2021-2023  | -26.0%  | 81.9% | -27.0%   | 0.5    | 17.0   |
| 2022-2024  | -152.0% | 81.9% | -172.0%  | 0.3    | 10.1   |
| 2023-2025  | -180.0% | 81.9% | -246.0%  | -0.9   | 17.2   |

**Analysis:**

*   **CAGR:**  Volatile, with periods of high growth followed by sharp declines. Recent periods show significant negative CAGR.
*   **MDD:**  High Maximum Drawdown (MDD) values consistently above 68%, indicating high risk and price volatility.
*   **Alpha:** Alpha is also quite volatile. In recent periods, it is dramatically negative, suggesting significant underperformance compared to its benchmark.
*   **Beta:** Beta fluctuates. High Beta means that the stock is more volatile than the market, and low Beta means it is less volatile than the market. In recent periods, it is more volatile than the market.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 145.88
*   **Previous Close:** 140.48
*   **Change:** 3.84 (Significant price increase)
*   **5-day SMA:** 136.87
*   **20-day SMA:** 129.06
*   **60-day SMA:** 108.23

**Analysis:** The current price is above all three moving averages, suggesting an uptrend. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA, further confirming this trend. The recent price jump of 3.84 further strengthens the upward momentum.

**3. RSI, PPO, and Divergence Analysis**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment)
*   **RSI:** 67.31 (Approaching overbought territory)
*   **PPO:** 0.21 (Positive, indicating a potential upward trend)
*   **Hybrid Signal:** Buy 80% of cash (3 shares - Caution - MRI:0.70)
*   **Recent (20 days) Relative Divergence Change:** 1.0 (Positive - short-term rise)
*   **Expected Return:** 85.7% (Excess return compared to S&P 500 if held long-term)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is approaching overbought levels, which could indicate a potential pullback in the near future.
*   The PPO is positive, which suggests a potential upward trend.
*   The hybrid signal gives a buy signal, but this must be considered with the MRI indicator of caution.
*   Despite recent price increases, the expected return is significantly higher than the S&P 500, indicating that the model expects the stock to perform well in the long term.

**4. Recent News & Significant Events**

*   Several news articles are positive, highlighting increased lithium prices, analyst target upgrades, and potential for income generation. Wells Fargo raising the price target to \$135 is also a positive sign, although the average price target provided (see below) is lower. These news items likely contributed to the recent price jump.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 2.42 (~Buy)
*   **Opinions:** 23
*   **Target Price (avg/high/low):** 123.32 / 200.00 / 75.00

**Analysis:** Analyst sentiment leans towards a "Buy" rating. However, the average target price of $123.32 is *below* the current price, suggesting limited upside potential according to analysts, or possibly outdated target prices. The wide range between the high and low target prices reflects uncertainty about the stock's future.

**5. Recent Earnings Analysis:**

| 날짜       | EPS     | 매출       |
|------------|---------|-------------|
| 2025-11-05 | -1.72   | 1.31 B$     |
| 2025-08-04 | -0.16   | 1.33 B$     |
| 2025-04-30 | 0       | 1.08 B$     |
| 2024-11-06 | -9.45   | 1.35 B$     |
| 2025-11-05 | -9.45   | 1.35 B$     |

**Analysis:** The earnings per share (EPS) has been volatile and recently negative. While revenue has remained relatively stable, the declining EPS indicates profitability concerns.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $1.31B | 8.99%         |
| 2025-06-30 | $1.33B | 14.80%         |
| 2025-03-31 | $1.08B | 14.51%         |
| 2024-12-31 | $1.23B | 11.22%         |
| 2024-09-30 | $1.35B | -7.68%         |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-09-30 | $10.00B   | -1.61%   |
| 2025-06-30 | $10.24B   | 0.22%    |
| 2025-03-31 | $10.03B   | 0.41%    |
| 2024-12-31 | $9.96B    | 0.76%    |
| 2024-09-30 | $10.24B   | -10.44%  |

**Analysis:**

*   **Revenue:** Generally consistent, but with some fluctuation.
*   **Profit Margin:**  Highly volatile, with a negative profit margin in Q3 2024. Recent quarters show improved, but inconsistent, profitability.
*   **Equity:** Relatively stable.
*   **ROE:** Return on Equity (ROE) is low and negative in the most recent quarter and Q3 2024, indicating inefficiency in generating profit from equity.

**7. Comprehensive Analysis**

Albemarle (ALB) presents a mixed picture.

*   **Positives:**
    *   Recent positive price momentum, supported by news of rising lithium prices and analyst upgrades.
    *   Medium investment recommendation
    *   Positive PPO indicator

*   **Negatives:**
    *   Significant underperformance relative to the S&P 500.
    *   Negative recent EPS and volatile profit margins.
    *   Low and recently negative ROE.
    *   High historical volatility.
    *   Average analyst target price below the current price, indicating potential overvaluation.
    *   Declining Alpha

*   **Overall:**

    ALB is a high-risk, high-reward investment at the moment. While recent price action is positive, fundamental indicators like EPS, ROE, and relative underperformance give cause for caution. The company's reliance on lithium prices makes it vulnerable to fluctuations in that market.

**Investment Recommendation:**

A cautious approach is warranted. While the potential for high returns exists, the high volatility and underlying financial concerns require careful monitoring. A smaller allocation might be appropriate for risk-tolerant investors who believe in the long-term growth of the lithium market. Investors should closely follow lithium prices, company earnings reports, and analyst updates.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.